Jakavi

ruxolitinib · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Jakavi, covering 2016-02-10 to 2025-11-10. Get the full timeline:

Most recent: EMA Authorised: Jakavi (ruxolitinib phosphate) — Novartis Europharm Limited